Look forward to noteworthy growth in the midline catheter market as it is projected to expand at a compound annual growth rate (CAGR) of 6.06% from 2025 to 2030 – manifesting from an already impressive estimated global market size of USD 3.01 billion as of 2024. The surge rests squarely on the expanding requirements for efficient, safer, and cost-effective medium-period intravenous access, especially in individuals requiring lengthy antibiotic therapy, fluid management, or chemotherapy.
Relevantly, an observed increase in chronic diseases such as cancer, diabetes, and cardiovascular disorders, coupled with the globally aging population, drives a higher demand for midline catheters in healthcare settings including hospitals and home care environments. As per CDC data released in October 2024, cardiovascular disease remains a principal cause of mortality, claiming one life every 33 seconds, and resulting in approximately 20% of all deaths in 2022.
The escalating number of hospital admissions and surgeries is a significant factor driving the midline catheter industry’s growth, as there is an increased demand for intravenous access that is safe, cost-effective, and efficient. With the rise in acute and chronic condition admissions, the demand for vascular access devices equipped to handle medium-term treatments such as fluid administration, antibiotics, and pain management is intensified. Two key benefits attributed to midline catheters (over short peripheral intravenous catheters) include fewer repetitive needle punctures for patients, thereby minimizing discomfort, and a consequent decrease in complications such as phlebitis and infiltration. These advantages, along with the lower risk of severe infections typically associated with central venous catheters, bolster their cost-effectiveness in fast-paced hospital settings.
In the face of an increasing traffic of hospital-based care and surgical interventions, coupled with worldwide healthcare systems’ enduring efforts to improve cost-management and minimize procedural complexity, the demand for midline catheters continues to rise.
Naturally, the increase in hospital admissions enhances the demand for intravenous therapies, consequently bolstering the usage of midline catheters, which provide vital safe, medium-period vascular access for in-patient treatment scenarios. Also, the prevalence of chronic diseases demanding lengthy intravenous therapy, such as administration of antibiotics, nutritional treatment, or chemotherapy, chiefly drives the demand for midline catheters. With safety features and enhanced patient comfort for medium-duration venous access, they emerge as the preferred choice in managing chronic care.
The midline catheter market also benefits from continuous innovation in catheter design and development, especially with newer models incorporating bio-compatible materials that drive down infection and thrombosis risks. The inclusion of ultrasound-aided insertion techniques has bettered placement precision while decreasing insertion-related complications. Moreover, the advent of antimicrobial-coated catheters and securement devices has improved midline catheters’ performance and safety, thereby boosting their adoption among healthcare practitioners.
The midline catheter industry has signaled a healthy pace of innovation in recent times, shaped by the dual need for safer vascular access devices and improved clinical outcomes. This has resulted in device manufacturers and researchers investing efforts into developing advanced catheters with improved biomaterials, antimicrobial coverings, and integrated technologies, all aimed at enhancing patient safety, protracting catheter dwelling duration, and reducing complications such as infections and thrombosis.
Regulations largely shape the midline catheter sector, influencing everything from product development and clinical adoption to market entry and post-market surveillance. Despite the stringent compliance conditions they enforce, these regulations are primarily designed to ensure patient safety and product effectiveness.
Overall, the booming midline catheter market can be primarily attributed to factors such as growing hospital admissions, escalating outpatient treatments, advancements in catheter technology, increased focus on patient safety, strict infection control protocols, and a higher incidence of chronic diseases requiring long-term intravenous therapy.
Source: https://www.grandviewresearch.com/industry-analysis/midline-catheter-market-report